Type Public Industry Pharmaceutical Founder Steve Kubby Parent organization Weedmaps | Traded as OTC Pink: CBIS Website cannabisscience.com Founded 2009 | |
 | ||
Products Pharmaceutical products Stock price CBIS (OTCMKTS) US$ 0.08 -0.01 (-8.31%)7 Mar, 4:00 PM GMT-5 - Disclaimer Headquarters Colorado Springs, Colorado, United States Subsidiaries Cannabis Consulting, Inc., Michigan Green Technologies, LLC, Equi-Pharm LLC Profiles | ||
Cannabis Science Inc. (OTC: CBIS) is a biotech company based in Colorado Springs, Colorado. The company was incorporated in 2009 and trades publicly under the ticker CBIS on the Over-The-Counter Bulletin Board. Their goal is to obtain Food and Drug Administration (FDA) approval for cannabis-based medicines, with a focus on treating skin cancer (basal and squamous cell carcinomas), Posttraumatic stress disorder and HIV. They are also studying the use of cannabinoids to treat sleep disorders.
The U.S. legal cannabis industry was valued at over $10 billion in 2015.
Management
The current CEO of Cannabis Science is co-founder Raymond C. Dabney. The previous CEO and Chairman, co-founder Robert Melamede Ph.D., is currently a professor of the Biology Department at University of Colorado Colorado Springs. Melamede is a renowned cannabinoid researcher, and teaches a class on cannabinoids.